Trade Intuitive Surgical, Inc. - ISRG CFD
Add to favourite- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
- Ownership
Spread | 0.24 | ||||||||
Long position overnight fee
Long position overnight fee
Go to platform | -0.026346% | ||||||||
Short position overnight fee
Short position overnight fee
Go to platform | 0.004124% | ||||||||
Overnight fee time | 22:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | USD | ||||||||
Margin | 5% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
*Information provided by Capital.com
Intuitive Surgical Inc ESG Risk Ratings
‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.
Prev. Close* | 309.26 |
Open* | 308.7 |
1-Year Change* | 14.46% |
Day's Range* | 308.7 - 313.13 |
52 wk Range | 222.65-358.07 |
Average Volume (10 days) | 1.83M |
Average Volume (3 months) | 40.71M |
Market Cap | 109.78B |
P/E Ratio | 73.43 |
Shares Outstanding | 352.07M |
Revenue | 6.85B |
EPS | 4.25 |
Dividend (Yield %) | N/A |
Beta | 1.35 |
Next Earnings Date | Jan 22, 2024 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Dec 6, 2023 | 310.21 | -0.24 | -0.08% | 310.45 | 313.42 | 307.39 |
Dec 5, 2023 | 309.26 | -1.69 | -0.54% | 310.95 | 311.22 | 303.53 |
Dec 4, 2023 | 311.74 | 0.74 | 0.24% | 311.00 | 315.14 | 308.67 |
Dec 1, 2023 | 315.12 | 5.75 | 1.86% | 309.37 | 315.59 | 308.29 |
Nov 30, 2023 | 310.25 | -0.46 | -0.15% | 310.71 | 311.66 | 303.52 |
Nov 29, 2023 | 310.66 | 0.10 | 0.03% | 310.56 | 316.17 | 309.46 |
Nov 28, 2023 | 310.75 | -0.24 | -0.08% | 310.99 | 312.64 | 308.95 |
Nov 27, 2023 | 314.92 | 0.54 | 0.17% | 314.38 | 315.76 | 311.86 |
Nov 24, 2023 | 317.70 | 1.60 | 0.51% | 316.10 | 318.00 | 315.54 |
Nov 22, 2023 | 315.62 | 1.73 | 0.55% | 313.89 | 317.21 | 313.35 |
Nov 21, 2023 | 311.74 | 1.78 | 0.57% | 309.96 | 312.09 | 307.83 |
Nov 20, 2023 | 311.27 | 6.17 | 2.02% | 305.10 | 312.10 | 304.08 |
Nov 17, 2023 | 305.08 | 0.65 | 0.21% | 304.43 | 311.07 | 304.41 |
Nov 16, 2023 | 303.86 | 7.41 | 2.50% | 296.45 | 305.13 | 294.01 |
Nov 15, 2023 | 293.20 | 1.86 | 0.64% | 291.34 | 297.17 | 291.06 |
Nov 14, 2023 | 291.60 | 4.50 | 1.57% | 287.10 | 294.02 | 287.10 |
Nov 13, 2023 | 282.40 | 0.01 | 0.00% | 282.39 | 289.46 | 280.74 |
Nov 10, 2023 | 277.49 | 6.80 | 2.51% | 270.69 | 278.41 | 269.13 |
Nov 9, 2023 | 272.19 | -3.96 | -1.43% | 276.15 | 278.35 | 271.70 |
Nov 8, 2023 | 277.79 | -1.30 | -0.47% | 279.09 | 282.25 | 276.37 |
Intuitive Surgical, Inc. Events
Time (UTC) | Country | Event |
---|---|---|
Monday, January 22, 2024 | ||
Time (UTC) 10:59 | Country US
| Event Q4 2023 Intuitive Surgical Inc Earnings Release Q4 2023 Intuitive Surgical Inc Earnings ReleaseForecast -Previous - |
Tuesday, April 16, 2024 | ||
Time (UTC) 10:59 | Country US
| Event Q1 2024 Intuitive Surgical Inc Earnings Release Q1 2024 Intuitive Surgical Inc Earnings ReleaseForecast -Previous - |
Friday, April 26, 2024 | ||
Time (UTC) 22:00 | Country US
| Event Intuitive Surgical Inc Annual Shareholders Meeting Intuitive Surgical Inc Annual Shareholders MeetingForecast -Previous - |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total revenue | 6222.2 | 5710.1 | 4358.4 | 4478.5 | 3724.2 |
Revenue | 6222.2 | 5710.1 | 4358.4 | 4478.5 | 3724.2 |
Cost of Revenue, Total | 2026.2 | 1751.6 | 1497.2 | 1368.3 | 1120.1 |
Gross Profit | 4196 | 3958.5 | 2861.2 | 3110.2 | 2604.1 |
Total Operating Expense | 4645.1 | 3889.1 | 3308.6 | 3104 | 2524.8 |
Selling/General/Admin. Expenses, Total | 1734 | 1459.2 | 1216.3 | 1177.6 | 941.4 |
Research & Development | 858.7 | 659.9 | 579.3 | 557.3 | 418.1 |
Unusual Expense (Income) | 20.3 | 11.1 | 15.8 | 0.8 | 45.2 |
Operating Income | 1577.1 | 1821 | 1049.8 | 1374.5 | 1199.4 |
Interest Income (Expense), Net Non-Operating | 29.7 | 69.3 | 157.2 | 127.7 | 80.1 |
Net Income Before Taxes | 1606.8 | 1890.3 | 1207 | 1502.2 | 1279.5 |
Net Income After Taxes | 1344.4 | 1728.1 | 1066.8 | 1381.8 | 1125.5 |
Minority Interest | -22.1 | -23.5 | -6.2 | -2.5 | 2.9 |
Net Income Before Extra. Items | 1322.3 | 1704.6 | 1060.6 | 1379.3 | 1128.4 |
Net Income | 1322.3 | 1704.6 | 1060.6 | 1379.3 | 1127.9 |
Income Available to Common Excl. Extra. Items | 1322.3 | 1704.6 | 1060.6 | 1379.3 | 1128.4 |
Income Available to Common Incl. Extra. Items | 1322.3 | 1704.6 | 1060.6 | 1379.3 | 1127.9 |
Diluted Net Income | 1322.3 | 1704.6 | 1060.6 | 1379.3 | 1127.9 |
Diluted Weighted Average Shares | 362 | 365.8 | 360.904 | 358.504 | 356.404 |
Diluted EPS Excluding Extraordinary Items | 3.65276 | 4.65992 | 2.93873 | 3.84738 | 3.16607 |
Dividends per Share - Common Stock Primary Issue | |||||
Diluted Normalized EPS | 3.69968 | 4.68766 | 2.97449 | 3.84943 | 3.27763 |
Total Extraordinary Items | -0.5 | ||||
Depreciation / Amortization | 5.9 | 7.3 |
Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
---|---|---|---|---|---|
Total revenue | 1743.7 | 1755.9 | 1696.2 | 1655 | 1557.4 |
Revenue | 1743.7 | 1755.9 | 1696.2 | 1655 | 1557.4 |
Cost of Revenue, Total | 576.5 | 584 | 583.2 | 544.1 | 505.3 |
Gross Profit | 1167.2 | 1171.9 | 1113 | 1110.9 | 1052.1 |
Total Operating Expense | 1277.9 | 1292.7 | 1308.6 | 1282.5 | 1158.5 |
Selling/General/Admin. Expenses, Total | 451.2 | 463.5 | 479.6 | 493 | 434.7 |
Research & Development | 241.3 | 242.2 | 244.2 | 235.7 | 216.2 |
Depreciation / Amortization | 0.8 | 0.8 | 0.9 | 1.3 | 1.4 |
Unusual Expense (Income) | 8.1 | 2.2 | 0.7 | 8.4 | 0.9 |
Operating Income | 465.8 | 463.2 | 387.6 | 372.5 | 398.9 |
Interest Income (Expense), Net Non-Operating | 56.2 | 36 | 34.2 | 22.2 | 3.9 |
Net Income Before Taxes | 522 | 499.2 | 421.8 | 394.7 | 402.8 |
Net Income After Taxes | 419.8 | 426 | 360.8 | 336.7 | 324.7 |
Minority Interest | -4.1 | -5.2 | -5.5 | -11.8 | -0.7 |
Net Income Before Extra. Items | 415.7 | 420.8 | 355.3 | 324.9 | 324 |
Net Income | 415.7 | 420.8 | 355.3 | 324.9 | 324 |
Income Available to Common Excl. Extra. Items | 415.7 | 420.8 | 355.3 | 324.9 | 324 |
Income Available to Common Incl. Extra. Items | 415.7 | 420.8 | 355.3 | 324.9 | 324 |
Diluted Net Income | 415.7 | 420.8 | 355.3 | 324.9 | 324 |
Diluted Weighted Average Shares | 358.2 | 357.3 | 356 | 356.9 | 360.5 |
Diluted EPS Excluding Extraordinary Items | 1.16052 | 1.17772 | 0.99803 | 0.91034 | 0.89875 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Diluted Normalized EPS | 1.17871 | 1.18298 | 0.99972 | 0.93042 | 0.90076 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total Current Assets | 6253 | 5844.9 | 6625.9 | 4662.6 | 4333.2 |
Cash and Short Term Investments | 4253.4 | 4341.2 | 5252.6 | 3221.7 | 3063.1 |
Cash & Equivalents | 1084 | 718.6 | 978.3 | 754.5 | 588.5 |
Short Term Investments | 2672.2 | 3050.3 | 3630 | 2054.1 | 2205.2 |
Total Receivables, Net | 942.1 | 782.7 | 645.5 | 645.2 | 682.3 |
Accounts Receivable - Trade, Net | 942.1 | 782.7 | 645.5 | 645.2 | 682.3 |
Total Inventory | 893.2 | 587.1 | 601.5 | 595.5 | 409 |
Prepaid Expenses | 144.8 | 116 | 108.3 | 196.7 | 178.8 |
Total Assets | 12974 | 13555 | 11168.9 | 9733.2 | 7846.7 |
Property/Plant/Equipment, Total - Net | 2456.4 | 1950.8 | 1641.2 | 1347.3 | 812 |
Property/Plant/Equipment, Total - Gross | 3694.3 | 2919.4 | 2398.9 | 1910.4 | 1248.2 |
Accumulated Depreciation, Total | -1237.9 | -968.6 | -757.7 | -563.1 | -436.2 |
Goodwill, Net | 348.5 | 343.6 | 336.7 | 307.2 | 240.6 |
Intangibles, Net | 49.8 | 70.5 | 77.4 | 112.1 | 66.7 |
Long Term Investments | 2623.6 | 4415.5 | 1757.7 | 2623.5 | 1771.3 |
Other Long Term Assets, Total | 1242.7 | 929.7 | 730 | 680.5 | 622.9 |
Total Current Liabilities | 1422.1 | 1149.8 | 965.2 | 1030.2 | 820.6 |
Accounts Payable | 147 | 121.2 | 81.6 | 123.5 | 100.7 |
Accrued Expenses | 781.7 | 597.3 | 486.1 | 529.8 | 386.5 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 493.4 | 431.3 | 397.5 | 376.9 | 333.4 |
Total Liabilities | 1932.1 | 1653.9 | 1437.4 | 1469.4 | 1167.9 |
Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Liabilities, Total | 439.3 | 453.7 | 444.6 | 418.3 | 338.6 |
Total Equity | 11041.9 | 11901.1 | 9731.5 | 8263.8 | 6678.8 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | |
Common Stock | 0.4 | 0.4 | 0.1 | 0.1 | 0.1 |
Additional Paid-In Capital | 7703.9 | 7164 | 6445.2 | 5756.8 | 5170.3 |
Retained Earnings (Accumulated Deficit) | 3500.1 | 4760.9 | 3261.3 | 2494.5 | 1521.7 |
Unrealized Gain (Loss) | -6.6 | -7.9 | 4.7 | 20.4 | -9.8 |
Other Equity, Total | -155.9 | -16.3 | 20.2 | -8 | -3.5 |
Total Liabilities & Shareholders’ Equity | 12974 | 13555 | 11168.9 | 9733.2 | 7846.7 |
Total Common Shares Outstanding | 350 | 357.7 | 353.104 | 348.003 | 343.503 |
Cash | 497.2 | 572.3 | 644.3 | 413.1 | 269.4 |
Minority Interest | 70.7 | 50.4 | 27.6 | 20.9 | 8.7 |
Other Current Assets, Total | 19.5 | 17.9 | 18 | 3.5 |
Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
---|---|---|---|---|---|
Total Current Assets | 8902.9 | 8031.8 | 6877 | 6253 | 6293.1 |
Cash and Short Term Investments | 6610.1 | 5933.8 | 4824.3 | 4253.4 | 4440.5 |
Cash | 474.3 | 520.3 | 605.2 | 497.2 | 536.3 |
Cash & Equivalents | 3127.7 | 2915.1 | 1537.8 | 1084 | 1001.7 |
Short Term Investments | 3008.1 | 2498.4 | 2681.3 | 2672.2 | 2902.5 |
Total Receivables, Net | 962.7 | 904.2 | 925.3 | 942.1 | 849.6 |
Accounts Receivable - Trade, Net | 962.7 | 904.2 | 925.3 | 942.1 | 849.6 |
Total Inventory | 1147.5 | 1005.2 | 946.6 | 893.2 | 837.1 |
Prepaid Expenses | 182.6 | 188.6 | 180.8 | 164.3 | 165.9 |
Total Assets | 14712.7 | 13903.3 | 13053.2 | 12974 | 13260.8 |
Property/Plant/Equipment, Total - Net | 3077 | 2830.8 | 2580.2 | 2456.4 | 2243.7 |
Goodwill, Net | 348.1 | 348.6 | 348.6 | 348.5 | 348.2 |
Intangibles, Net | 41.8 | 47.2 | 44.8 | 49.8 | 57.1 |
Long Term Investments | 1044.9 | 1332.5 | 1886.4 | 2623.6 | 3078.1 |
Other Long Term Assets, Total | 1298 | 1312.4 | 1316.2 | 1242.7 | 1240.6 |
Total Current Liabilities | 1676.4 | 1538.4 | 1307.4 | 1422.1 | 1233.4 |
Accounts Payable | 196.2 | 199.7 | 164.1 | 147 | 164.2 |
Accrued Expenses | 742.6 | 703.3 | 600.1 | 781.7 | 639.1 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 737.6 | 635.4 | 543.2 | 493.4 | 430.1 |
Total Liabilities | 2173.7 | 2024.2 | 1835.5 | 1932.1 | 1745.4 |
Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 84.5 | 80.6 | 76.5 | 70.7 | 58.6 |
Other Liabilities, Total | 412.8 | 405.2 | 451.6 | 439.3 | 453.4 |
Total Equity | 12539 | 11879.1 | 11217.7 | 11041.9 | 11515.4 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | 0 |
Common Stock | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 |
Additional Paid-In Capital | 8385.9 | 8150.8 | 7928.4 | 7703.9 | 7684.8 |
Retained Earnings (Accumulated Deficit) | 4209.2 | 3807.7 | 3397.4 | 3500.1 | 4017.8 |
Unrealized Gain (Loss) | 10.3 | -103.5 | -116.6 | -6.6 | -177.4 |
Other Equity, Total | -66.8 | 23.7 | 8.1 | -155.9 | -10.2 |
Total Liabilities & Shareholders’ Equity | 14712.7 | 13903.3 | 13053.2 | 12974 | 13260.8 |
Total Common Shares Outstanding | 352 | 351.3 | 350.4 | 350 | 353.3 |
Property/Plant/Equipment, Total - Gross | 4545.2 | ||||
Accumulated Depreciation, Total | -1468.2 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Net income/Starting Line | 1344.4 | 1728.1 | 1066.8 | 1381.8 | 1125 |
Cash From Operating Activities | 1490.8 | 2089.4 | 1484.8 | 1598.2 | 1169.6 |
Cash From Operating Activities | 338 | 282.8 | 226.4 | 160 | 108.6 |
Amortization | 54.4 | 49.4 | 66.9 | 56.1 | 24.8 |
Deferred Taxes | -185.3 | -62.6 | 57.6 | -8 | 31.9 |
Non-Cash Items | 558.4 | 459.8 | 340.3 | 329.8 | 263 |
Cash Taxes Paid | 444.2 | 180 | 34.4 | 158.6 | 179.2 |
Changes in Working Capital | -619.1 | -368.1 | -273.2 | -321.5 | -383.7 |
Cash From Investing Activities | 1370.8 | -2461.5 | -940.6 | -1154.4 | -1049.6 |
Capital Expenditures | -532.4 | -353.5 | -341.5 | -425.6 | -187.4 |
Other Investing Cash Flow Items, Total | 1903.2 | -2108 | -599.1 | -728.8 | -862.2 |
Cash From Financing Activities | -2572.3 | 43 | -85.7 | -168.4 | 126.3 |
Financing Cash Flow Items | -198.7 | -233.5 | -260.2 | -171.7 | -110.3 |
Issuance (Retirement) of Stock, Net | -2373.6 | 276.5 | 174.5 | 3.3 | 236.6 |
Foreign Exchange Effects | 5.4 | -3.4 | -2.6 | -2.2 | -0.1 |
Net Change in Cash | 294.7 | -332.5 | 455.9 | 273.2 | 246.2 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | 360.8 | 1344.4 | 1007.7 | 683 | 369.4 |
Cash From Operating Activities | 371.4 | 1490.8 | 1052.9 | 669.7 | 223 |
Cash From Operating Activities | 87.7 | 338 | 239.4 | 157.5 | 77.7 |
Amortization | 12.4 | 54.4 | 40.9 | 25.9 | 12.7 |
Deferred Taxes | 9.3 | -185.3 | -102 | -40.1 | -14.4 |
Non-Cash Items | 144.7 | 558.4 | 425.2 | 277.5 | 143 |
Changes in Working Capital | -243.5 | -619.1 | -558.3 | -434.1 | -365.4 |
Cash From Investing Activities | 573.1 | 1370.8 | 796 | 251.5 | -214.7 |
Capital Expenditures | -194.1 | -532.4 | -394.7 | -225.6 | -95.1 |
Other Investing Cash Flow Items, Total | 767.2 | 1903.2 | 1190.7 | 477.1 | -119.6 |
Cash From Financing Activities | -381.2 | -2572.3 | -1608.8 | -682 | -199.9 |
Financing Cash Flow Items | -131.4 | -198.7 | -190.8 | -182 | -173.4 |
Issuance (Retirement) of Stock, Net | -249.8 | -2373.6 | -1418 | -500 | -26.5 |
Foreign Exchange Effects | 1.8 | 5.4 | 7.9 | 6 | 3.8 |
Net Change in Cash | 565.1 | 294.7 | 248 | 245.2 | -187.8 |
Investor Name | Investor Type | Percent Outstanding | Shares Held | Shares change | Holdings Date | Turnover Rating |
---|---|---|---|---|---|---|
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 8.3842 | 29518477 | 156170 | 2023-06-30 | LOW |
T. Rowe Price Associates, Inc. | Investment Advisor | 5.2672 | 18544358 | -1399906 | 2023-06-30 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 4.818 | 16962733 | 599763 | 2023-06-30 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 4.2067 | 14810625 | 274201 | 2023-06-30 | LOW |
Fidelity Management & Research Company LLC | Investment Advisor | 2.2672 | 7982242 | 667250 | 2023-06-30 | LOW |
Capital World Investors | Investment Advisor | 2.1333 | 7510586 | 39671 | 2023-06-30 | LOW |
AllianceBernstein L.P. | Investment Advisor/Hedge Fund | 1.9763 | 6957880 | -46991 | 2023-06-30 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.8782 | 6612636 | 167641 | 2023-06-30 | LOW |
Invesco Capital Management (QQQ Trust) | Investment Advisor | 1.7002 | 5985880 | 47551 | 2023-09-30 | LOW |
JP Morgan Asset Management | Investment Advisor | 1.6089 | 5664468 | 1002535 | 2023-06-30 | LOW |
Edgewood Management LLC | Investment Advisor/Hedge Fund | 1.3911 | 4897684 | -1167916 | 2023-06-30 | LOW |
Fisher Investments | Investment Advisor/Hedge Fund | 1.2623 | 4444151 | 55720 | 2023-06-30 | LOW |
Jennison Associates LLC | Investment Advisor/Hedge Fund | 1.2243 | 4310498 | -145727 | 2023-06-30 | LOW |
Baillie Gifford & Co. | Investment Advisor | 1.1703 | 4120421 | -58814 | 2023-06-30 | LOW |
Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 0.9798 | 3449633 | 399513 | 2022-12-31 | LOW |
BlackRock Investment Management (UK) Ltd. | Investment Advisor/Hedge Fund | 0.917 | 3228512 | 39269 | 2023-06-30 | LOW |
Nuveen LLC | Pension Fund | 0.9104 | 3205086 | -331379 | 2023-06-30 | LOW |
Walter Scott & Partners Ltd. | Investment Advisor/Hedge Fund | 0.8786 | 3093348 | -72651 | 2023-09-30 | LOW |
BlackRock Financial Management, Inc. | Investment Advisor/Hedge Fund | 0.8465 | 2980361 | 81086 | 2023-06-30 | LOW |
BlackRock Asset Management Ireland Limited | Investment Advisor | 0.7489 | 2636528 | 68160 | 2023-06-30 | LOW |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Intuitive Company profile
Intuitive Surgical, Inc. (ISRG) is a developer of minimally invasive, robot-assisted surgery. The company develops, manufactures and markets the da Vinci surgical system.
Established in 1995, Intuitive is headquartered in California and operates across the US, Western Europe, and the Asia Pacific regions. It also operates in China through Intuitive Fosun, a joint venture with Fosun Pharma.
The da Vinci Surgical System helps physicians and healthcare providers conduct complex surgery with the help of robots. The process reduces variability in surgery, and helps deliver better care and early recovery.
Intuitive also designed and developed Ion, a robot-assisted endoluminal platform. Ion is designed to perform peripheral lung biopsies with the help of an advanced ultra-thin, ultra-manoeuvrable catheter that allows navigation far into the peripheral lung. The technology is precise and gives unprecedented stability.
Along with the launch of the da Vinci surgical system, Intuitive Surgical went public in 2000, trading on the Nasdaq stock exchange under the ticker symbol ISRG.
Check out ISRG’s price history and today’s quote, and follow the ups and downs of the share value at Capital.com. Stay on top of the latest price developments with our live ISRG stock chart.
Industry: | Advanced Medical Equipment & Technology (NEC) |
1020 Kifer Road
SUNNYVALE
CALIFORNIA 94086
US
Income Statement
- Annual
- Quarterly
News

December RBA preview: no move expected at the final meeting of 2023
The RBA meets on Tuesday, 5th of December, 2023, at 2.30 PM (AEDT). We preview what to expect from this month’s decision.
14:47, 4 December 2023
CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs
CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs
12:39, 30 November 2023
Euro Zone CPI expected to continue dropping; economists warn about cutting too soon
EZ PI expected to drop further but speed of decline
08:16, 29 November 2023
A weaker Dollar drives gold higher
Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.
13:49, 28 November 2023
Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain
US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.
13:20, 28 November 2023
RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023
The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.
13:04, 28 November 2023
Crude prices slide on OPEC+ uncertainty
Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.
12:55, 28 November 2023People also watch
Still looking for a broker you can trust?
Join the 570.000+ traders worldwide that chose to trade with Capital.com